EMILY BELTRAN: Open Payments
NPI 1316653850 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,291 in 70 payments from 20 companies in 2025. Trend: 2023 $738 · 2024 $971 · 2025 $1,291
Food & beverage: $1,291
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $268 |
| PFIZER INC. | 15 | $252 |
| GlaxoSmithKline, LLC. | 5 | $93 |
| Almatica Pharma LLC | 5 | $86 |
| ABBVIE INC. | 5 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $77 |
| Lundbeck LLC | 4 | $73 |
| Astellas Pharma US Inc | 2 | $54 |
| Amgen Inc. | 3 | $49 |
| Lilly USA, LLC | 3 | $47 |
Products named: NURTEC ODT, ELIQUIS, Wegovy, Ozempic, LOREEV XR, JARDIANCE, Rybelsus, REXULTI.
Industry payments across NV — which companies pay providers there.
